LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.71 | 27.76 | 2621 | 2877 | 0.9108 | 0.9723 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.71 | 27.76 | 2651 | 2877 | 0.9212 | 0.9757 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.71 | 27.76 | 3809 | 2877 | 1.3237 | 1.0855 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.71 | 27.76 | 3849 | 2877 | 1.3376 | 1.0888 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.41 | 27.76 | 2791 | 3105 | 0.8987 | 0.9689 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.41 | 27.76 | 2832 | 3105 | 0.9119 | 0.9731 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.41 | 27.76 | 4072 | 3105 | 1.3112 | 1.0812 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.41 | 27.76 | 4106 | 3105 | 1.3221 | 1.0838 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.11 | 27.76 | 3020 | 3331 | 0.9065 | 0.9718 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.11 | 27.76 | 3062 | 3331 | 0.9191 | 0.9757 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.11 | 27.76 | 4321 | 3331 | 1.2970 | 1.0767 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.11 | 27.76 | 4364 | 3331 | 1.3099 | 1.0797 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.81 | 27.76 | 3203 | 3596 | 0.8906 | 0.9673 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.81 | 27.76 | 3243 | 3596 | 0.9018 | 0.9708 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.81 | 27.76 | 4671 | 3596 | 1.2988 | 1.0759 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 42.81 | 27.76 | 4718 | 3596 | 1.3119 | 1.0789 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.52 | 27.76 | 3407 | 3884 | 0.8771 | 0.9636 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.52 | 27.76 | 3452 | 3884 | 0.8887 | 0.9672 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.52 | 27.76 | 5014 | 3884 | 1.2908 | 1.0729 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 44.52 | 27.76 | 5052 | 3884 | 1.3006 | 1.0751 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.22 | 27.76 | 3682 | 4125 | 0.8926 | 0.9688 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.22 | 27.76 | 3724 | 4125 | 0.9028 | 0.9719 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.22 | 27.76 | 5339 | 4125 | 1.2943 | 1.0728 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 46.22 | 27.76 | 5392 | 4125 | 1.3072 | 1.0756 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.93 | 27.76 | 3933 | 4421 | 0.8895 | 0.9683 | MN20160318_Q01 | E09 |